Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia
Crossref DOI link: https://doi.org/10.1007/s13300-018-0426-0
Published Online: 2018-04-26
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lalić, Nebojša
Russel-Szymczyk, Monika
Culic, Marina
Tikkanen, Christian Klyver
Chubb, Barrie
Funding for this research was provided by:
Novo Nordisk
Article History
Received: 23 February 2018
First Online: 26 April 2018